Metastatic renal cell cancer--is the outlook really improving?
Waxman
J
J
Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Thomas
H
H
D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy*; D009362:Neoplasm Metastasis; D011379:Prognosis
D007376:Interleukin-2; D007372:Interferons